“…Next, we compared the list of transcripts found to be differentially expressed in CMVMJD135 mice with 40 different datasets of previously reported DEGs, which include, among others, data on the microglial signature program [ 49 , 50 ] on other neurodegenerative disorders [ 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 ], aging [ 38 , 51 , 63 ], disease-associated microglia (DAM) [ 64 ], and injury-related microglia [ 38 , 51 ]. We found a significant overlap with only 3 of the 40 published gene sets, namely with the DEGs seen in microglia of a mouse model of amyotrophic lateral sclerosis (ALS), the SOD1 G93A mouse model [ 52 ]; of a mouse model of Alzheimer disease (AD), the App NL-G-F/NL-G-F mouse model [ 52 ]; and with a list of microglial genes highly expressed and/or affected in different neuroinflammatory conditions [ 65 ] ( Figure S13 in Supplementary Results and Supplementary Data 2 ).…”